Effect of daclizumab high-yield process in patients with highly active relapsing-remitting multiple sclerosis

Patients with highly active relapsing-remitting multiple sclerosis (RRMS) are at greater risk for disease progression and may respond differently to MS therapeutics than those with less active disease. The current post hoc analysis evaluated the effects of daclizumab high-yield process (DAC HYP) vs....

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Giovannoni, Gavin, Radue, Ernst-Wilhelm, Havrdova, Eva, Riester, Katherine, Greenberg, Steven, Mehta, Lahar, Elkins, Jacob
Format: Artigo
Sprog:Inglês
Udgivet: Springer Berlin Heidelberg 2013
Fag:
Original Communication
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915085/
https://ncbi.nlm.nih.gov/pubmed/24375015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-013-7196-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker